Pediatric Gastroenterology
Lindsey G. Albenberg, DO
Independent provider
Accepting new patients
Sees newborns through age 14
CHOP Specialty Care, Lancaster

About me

  • Assistant Professor of Pediatrics (Gastroenterology, Hepatology and Nutrition) at the Children's Hospital of Philadelphia

Education and training

  • Medical School: Kansas City University of Medicine and Biosciences
  • Residency: Children's Mercy Hospital
  • Fellowship: Children's Hospital of Philadelphia

Insurance accepted

My Locations

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Lancaster General Hospital: Has privileges to treat patients in the hospital.
Dr. Albenberg is an independent physician who is not employed by Penn Medicine Lancaster General Health.

Qualifications and experience

Treatments and Conditions

My research

Flibotte J, Dalembert G, Albenberg L, Bamat T, Barnes A, Carroll B, Nathanson J, Rezet B, Szalda D, Washington N, Weiss A, Ronan JC. Informing differentiated training for pediatric residents in the new ACGME landscape: guidance through a survey of subspecialty faculty. , Association of Pediatric Program Directors Annual Spring Meeting, Atlanta, GA: 2025


Mitchel EB, Dolinger MT, Constant B, Wang Z, Guisado D, Gao M, Fusillo S, Baldassano RN, Kelsen J, Dubinsky M, Huang J, Albenberg L. Ustekinumab is safe and effective in pediatric patients with Crohn's disease , J Pediatr Gastroenterol Nutr: 2025,doi: 10.1002


Breton J, Tu V, Tanes C, Wilson N, Quinn R, Kachelries K, Friedman ES, Bittinger K, Baldassano RN, Compher C, Albenberg L. A pro-inflammatory diet is associated with growth and virulence of Escherichia coli in pediatric Crohn's disease , J Crohns Colitis: 2025,doi: 10.1093


Lachman D, Orlanski-Meyer E, Lev-Tzion R, Ledder O, Assa A, Shavit-Brunschwig Z, Yerushalmi B, Aloi M, Griffiths AM, Albenberg L, Bar-Or I, Kolho KL, Shouval DS, Cohen S, Turner D, Atia O. Long-term outcome of pediatric acute severe colitis: A prospective 5-year follow-up of the PRASCO trial , J Pediatr Gastroenterol Nutr: 2024,doi: 10.1002


Lewis JD, Daniel SG, Li H, Hao F, Patterson AD, Hecht AL, Brensinger CM, Wu GD, Bittinger K; DINE-CD; SPARC IBD Investigators. Surgery for Crohn's Disease Is Associated With a Dysbiotic Microbiome and Metabolome: Results From Two Prospective Cohorts , Cell Mol Gastroenterol Hepatol, 18(3): 2024,101357


Joel MA, Cooper M, Peebles R, Albenberg L, Timko CA. Clinical characterization of Co-morbid autoimmune disease and eating disorders: a retrospective chart review , Eat Disord, 32(4): 2024,353-368


Kennedy KV, Umeweni CN, Alston M, Dolinsky L, McCormack SM, Taylor LA, Bendavid A, Benitez A, Mitchel E, Karakasheva T, Goh V, Maqbool A, Albenberg L, Brown-Whitehorn T, Cianferoni A, Muir AB. Esophageal Remodeling Correlates With Eating Behaviors in Pediatric Eosinophilic Esophagitis , Am J Gastroenterol, 119(6): 2024,1167-1176


Daniel D, Wu GD, Walters W, Compher C, Ni J, Delaroque C, Albenberg L, Ley RE, Patterson AD, Lewis JD, Gewirtz AT, Chassaing B Human Intestinal Microbiome Determines Individualized Inflammatory Response to Dietary Emulsifier Carboxymethylcellulose Consumption , Cell Mol Gastroenterol Hepatol, 17(2): 2024,315-318


Leiby A, Albenberg L, Langseder A, Kennedy M, Pressman N, Chiu S, Rosh JR. A prospective, controlled multisite trial of yoga in pediatric inflammatory bowel disease , J Pediatr Gastroenterol Nutr, 78(2): 2024,272-279


Constant BD, Albenberg L, Mitchel EB, De Zoeten EF, Clapp JT, Scott FI; PRIOR AUTHORIZATION IMPACT NETWORK STUDY GROUP. Prior Authorizations Delay Therapy, Impact Decision-making, and Lead to Adverse Events in Inflammatory Bowel Disease: 2022 Provider Survey , Clin Gastroenterol Hepatol, 22(2): 2024,423-426